Please login to the form below
Austria
This page shows the latest Austria news and features for those working in and with pharma, biotech and healthcare.
Sandoz reveals antibiotic manufacturing expansion plans in Europe
Novartis’ generics division Sandoz is planning to expand its antibiotics manufacturing network by boosting its production capabilities in Austria and Spain. ... The government funding primarily went towards new process technology to produce active
Latest news
-
Novartis agrees to help produce Roche’s repurposed COVID-19 drug
Deliveries of the CVnCoV doses from Novartis’ Kundl, Austria manufacturing site are expected to begin in summer 2021.
-
EMA says there is ‘no indication’ AZ/Oxford’s COVID-19 vaccine causes blood clots
Other EU member states – Italy and Austria – have suspended vaccination from certain batches of the vaccine, although the suspensions in each country involves different batches. ... According to the BBC, Estonia, Latvia, Lithuanian and Luxembourg
-
CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
Deliveries of the CVnCoV doses from Novartis’ Kundl, Austria manufacturing site are expected to begin in summer 2021.
-
Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m
The government funding primarily went towards new process technology to produce API for penicillin in Kundl, Austria.
-
GSK and CureVac look to develop next-generation mRNA COVID-19 vaccines
in all countries except Germany, Austria and Switzerland.
More from news
Approximately 1 fully matching, plus 114 partially matching documents found.
Latest Intelligence
-
Attracting doctors to low-demand specialties
project. This global programme attracted candidates from Austria, Belgium, Canada, China, France, Italy, the Netherlands, Taiwan, the UK and the USA.
-
Market access in Europe: balancing access and affordability
The alliance has subsequently expanded to include Luxembourg and Austria, with Ireland expected to be the next country to become a member.
-
Charting a course for expansion
Germany and the UK are first, Austria, Denmark and the Netherlands are right there with us - it's really their timing that determines it, not just ours.
-
Immunisation politicised
Reshaping the HPV vaccine in Austria. While swift in other European countries, implementation took several years in Austria. ... to do so, Austria became a 'European frontrunner' in gender-neutral HPV vaccination.
-
Safe from harm?
In Germany (75%), Austria (71%), Canada (66%), Finland (65%) and the US (64%), patients were most likely to work with the physician so that both of them have input into decision.
More from intelligence
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
UDG Healthcare company Ashfield Engage has announced the appointment of Serap Becker (pictured above) as its new head of patient solutions in the DACH region (Austria, Germany, and Switzerland).
-
RSA boosts its German speaking divisions
Appoints Andreas Reimer and Ji Kwon. RSA has appointed Andreas Reimer and Ji Kwon (pictured) to strengthen its operations in Germany, Austria and Switzerland (DACH).
-
EMA elects Dr Christa Wirthumer-Hoche new vice chair
She has been involved in the European medicines regulatory network since 1995, when Austria joined the European Union, has was a member of the Coordination Group for Mutual Recognition and Decentralised
-
Arvato turns to Google for head of digital marketing
Monsees joins from Google, where he was most recently responsible for the automotive, consumer goods and healthcare divisions in Germany, Austria and Switzerland.
-
UCB’s chair Gerhard Mayr joins Almirall board
company OMV and the Bank of Austria.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Random42 Bring Medical Animation to Bio-Europe Spring 2019
The convention runs from March 25th–27th and is being held at the Messe Wien Exhibition and Congress Center, Vienna, Austria.
-
Attracting doctors to low-demand specialties: A role for industry?
project. This global programme attracted candidates from Austria, Belgium, Canada, China, France, Italy, the Netherlands, Taiwan, the UK and the USA.
-
Plugging knowledge gaps to demonstrate the benefits of new medicines
Outcomes Research in Vienna, Austria. .
-
Dr. Thomas Blatter has been appointed Vice President, DACH Region
From Anthill’s Freiburg office, Dr. Blatter will liaise with local affiliates of life science companies operating in Germany, Austria and Switzerland – helping them plan and execute digital marketing solutions that
-
Anthill expands its services in DACH region
Anthill, a digital communications agency focused on the life science industry, is expanding its services for local clients based in Germany, Austria and Switzerland.
More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Why pharma must get smart in its approach to customer engagement
- GSK appoint Tony Wood as chief scientific officer
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- Ipsen’s Sohonos approved by Health Canada
- Personalised medicine: driving a need for greater diversity in clinical trials
- Live Webinar: Protecting Ownership of Technological & Pharmaceutical Innovation
- Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy
- Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
- SMC approves Parkinson’s disease treatment Ongentys
- Why pharma must get smart in its approach to customer engagement
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE
- FDA nod for Janssen schizophrenia treatment Invega Hafyera
- Merck KGaA and Pfizer collaborate on lupus
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- Personalised medicine: driving a need for greater diversity in clinical trials
- Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
